Chemocentryx Net Cash Flow or Change in Cash and Cash Equivalents Trend from 2010 to 2021

CCXI -  USA Stock  

USD 15.99  0.58  3.50%

Chemocentryx Net Cash Flow or Change in Cash and Cash Equivalents is increasing over the last several years with very volatile swings. Net Cash Flow or Change in Cash and Cash Equivalents is predicted to flatten to -7,063,105. . Chemocentryx Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 2.64 Million. The current Selling General and Administrative Expense is estimated to increase to about 45.5 M, while Consolidated Income is projected to decrease to (56.8 M).

Search Historical Trends 

 
Refresh
Check Chemocentryx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemocentryx main balance sheet or income statement drivers, such as Gross Profit of 54.5 M, Interest Expense of 2.9 M or Operating Expenses of 98.9 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0482, PPandE Turnover of 4.86 or Receivables Turnover of 446. Chemocentryx financial statements analysis is a perfect complement when working with Chemocentryx Valuation or Volatility modules. It can also supplement various Chemocentryx Technical models. Continue to the analysis of Chemocentryx Correlation against competitors.

Chemocentryx Quarterly Net Cash Flow or Change in Cash and Cash Equivalents

8.66 MillionShare

Chemocentryx Net Cash Flow or Change in Cash and Cash Equivalents Breakdown

Showing smoothed Net Cash Flow or Change in Cash and Cash Equivalents of Chemocentryx with missing and latest data points interpolated. Principal component of the cash flow statement representing the amount of increase (decrease) in cash and cash equivalents. Includes Net Cash Flow from Operations; investing Net Cash Flow from Investing and financing Net Cash Flow from Financing for continuing and discontinued operations; and the effect of exchange rate changes on cash [NCFX].Chemocentryx's Net Cash Flow or Change in Cash and Cash Equivalents historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemocentryx's overall financial position and show how it may be relating to other accounts over time.
Net Cash Flow or Change in Cash and Cash Equivalents10 Years Trend
Increasing
Very volatile
 Net Cash Flow or Change in Cash and Cash Equivalents 
Share
      Timeline 

Chemocentryx Net Cash Flow or Change in Cash and Cash Equivalents Regression Statistics

Arithmetic Mean 436,491
Coefficient Of Variation 3,842
Mean Deviation 12,283,091
Median(799,000)
Standard Deviation 16,768,521
Range 59,794,000
R-Value 0.0106
R-Squared 0.00011235
Significance 0.97
Slope 49,297

Chemocentryx Net Cash Flow or Change in Cash and Cash Equivalents History

201128.1 M
2012-31.7 M
20131.8 M
20145.8 M
2015-3.3 M
2016-799 K
201728 M
2018-11.9 M
201912.2 M
2020-6.9 M
2021-7.1 M

About Chemocentryx Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Chemocentryx income statement, its balance sheet, and the statement of cash flows. Chemocentryx investors use historical funamental indicators, such as Chemocentryx's Net Cash Flow or Change in Cash and Cash Equivalents, to determine how well the company is positioned to perform in the future. Although Chemocentryx investors may use each financial statement separately, they are all related. The changes in Chemocentryx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemocentryx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chemocentryx Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chemocentryx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Net Cash Flow or Change in Cash and Cash Equivalents-6.9 M-7.1 M
Free Cash Flow-96.6 M-99.1 M
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Chemocentryx Investors Sentiment

The influence of Chemocentryx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemocentryx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - CCXI

Chemocentryx Investor Sentiment

Most of Macroaxis users are currently bullish on Chemocentryx. What is your opinion about investing in Chemocentryx? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to the analysis of Chemocentryx Correlation against competitors. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.